Prospect: Patient Information
Ibuprofen Liderfarm 600 mg film-coated tablets EFG
Read the entire prospectus carefully before starting to take this medication, as it contains important information for you.
Contents of the Prospectus
Ibuprofen belongs to the group of medications called non-steroidal anti-inflammatory drugs (NSAIDs).
This medication is indicated for the treatment of fever, treatment of mild or moderate pain, including migraine, treatment of arthritis (inflammation of the joints, including hands and feet, leading to swelling and pain), juvenile rheumatoid arthritis, osteoarthritis (a chronic disorder that causes cartilage damage), ankylosing spondylitis (inflammation that affects the joints of the spine), non-rheumatic inflammation, and primary dysmenorrhea (painful menstruation).
Do not take Ibuprofen Liderfarm:
Warnings and precautions:
Consult your doctor or pharmacist before starting to take ibuprofen:
Infections
Ibuprofeno Liderfarm may mask the signs of an infection, such as fever and pain. Consequently, Ibuprofeno Liderfarm may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
It is essential that you use the smallest dose that relieves/controls the pain and do not take this medication for longer than necessary to control your symptoms.
Skin reactions
Severe skin reactions have been reported in association with ibuprofen treatment. Stop taking ibuprofen and go to the doctor immediately if you present any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these may be the first signs of a severe skin reaction. See section 4.
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue treatment with Ibuprofeno Farmalider and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Cardiovascular precautions
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking Ibuprofeno Liderfarm if:
Precautions during pregnancy and in women of childbearing age
Because the administration of medications of the Ibuprofen type has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of ibuprofen is contraindicated.
For women of childbearing age, it should be taken into account that medications of the Ibuprofen type have been associated with a decrease in fertility.
Taking Ibuprofeno Liderfarm with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Ibuprofeno Liderfarm may affect or be affected by other medications. For example:
Other non-steroidal anti-inflammatory medications, such as aspirin
Other medications may also affect or be affected by treatment with Ibuprofeno Liderfarm. Therefore, you should always consult your doctor or pharmacist before using Ibuprofeno Liderfarm with other medications.
Interference with laboratory tests
Taking ibuprofen may alter the following laboratory tests:
Inform your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Ibuprofeno Liderfarm with food and beverages
You can take it alone or with food. In general, it is recommended to take it before meals or with milk to reduce the possibility of stomach discomfort.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take Ibuprofeno Liderfarm if you are in the last 3 months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's ability to bleed and delay or prolong delivery more than expected. You should not take Ibuprofeno Liderfarm during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, Ibuprofeno Liderfarm may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for a period longer than a few days, your doctor may recommend additional checks.
Pregnancy
Ibuprofen should not be taken during pregnancy, especially during the third trimester.
Breastfeeding
Although only small amounts of the medication pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
Therefore, if you become pregnant or are breastfeeding, consult your doctor.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medication, you should not drive or operate hazardous machinery. If you only take one dose of ibuprofen or for a short period, you do not need to take special precautions.
Ibuprofeno Liderfarm contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions of this medication indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of treatment with Ibuprofeno. Do not discontinue treatment before, as the expected results will not be achieved. Similarly, do not use Ibuprofeno for longer than indicated by your doctor.
It is essential that you use the smallest dose that relieves/controls the pain and do not take this medication for longer than necessary to control your symptoms.
This medication is administered orally.
The effective lowest dose should be used for the shortest necessary time to alleviate symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
Adults
In adults and adolescents from 14 to 18 years, take one tablet (600 mg) every 6 to 8 hours, depending on the intensity of the condition and response to treatment.
In some cases, higher doses may be required, but in any case, it is recommended not to exceed the maximum daily dose of 2400 mg in adults and 1600 mg in adolescents from 12 to 18 years.
Use in children and adolescents
The use of this medication is not recommended in children and adolescents under 14 years, as the dose of ibuprofen it contains is not suitable for the recommended dosage in this group of patients.
Elderly patients
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If so, the dose can only be increased once your doctor has checked that you tolerate the medication well.
Patients with kidney and/or liver disease
If you have kidney or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
If you think the effect of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Ibuprofeno Liderfarm than you should
If you have taken more Ibuprofeno than you should, or have accidentally ingested the contents of the package, consult your doctor or pharmacist immediately or the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the package and the medication prospectus to the healthcare professional. If a severe overdose has occurred, the doctor will take the necessary measures.
If you have taken more Ibuprofeno Liderfarm than you should, or if a child has accidentally ingested the medication, consult a doctor immediately or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
The symptoms of overdose include nausea, vomiting, abdominal pain (which may contain bloody vomit), headache, ringing in the ears, confusion, and involuntary eye movement. At high doses, symptoms such as drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, chills, and breathing problems have been reported. Rarely, more severe symptoms such as gastrointestinal bleeding, low potassium levels in the blood, low blood pressure, convulsions, and respiratory changes may occur.
If you forget to take Ibuprofeno Liderfarm
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time for the next dose is near, skip the forgotten dose and take the next dose at the usual time.
Like all medications, Ibuprofeno Liderfarm may produce adverse effects, although not all people suffer from them.
Adverse effects of medications like Ibuprofeno are more common in people over 65 years old.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
Frequencies are established according to the following classification: very frequent (may affect more than 1 in 10 people); frequent (may affect up to 1 in 10 people); infrequent (may affect up to 1 in 100 people); rare (may affect up to 1 in 1000 people); very rare (may affect up to 1 in 10,000 people); unknown frequency (cannot be estimated from available data).
The following adverse effects have been observed:
Gastrointestinal
The most frequent adverse effects that occur with medications like Ibuprofeno are gastrointestinal: peptic ulcers, digestive bleeding, perforations (in some cases fatal), especially in the elderly. Nausea, vomiting, diarrhea, flatulence, constipation, heartburn, abdominal pain, blood in stool, oral ulcers, worsening of ulcerative colitis, and Crohn's disease have also been observed. Less frequently, gastritis has been observed.
Other adverse effects are: Infrequent: inflammation of the oral mucosa with ulcer formation. Rare: esophageal inflammation, esophageal narrowing (esophageal stenosis), exacerbation of intestinal diverticulitis, hemorrhagic colitis (gastroenteritis with bloody diarrhea). Very rare: pancreatitis.
Cardiovascular
Medications like Ibuprofeno may be associated with a moderate increased risk of suffering a heart attack ("myocardial infarction") or stroke.
Edema (fluid retention), arterial hypertension, and heart failure have also been observed in association with treatments with medications of the Ibuprofeno type.
Dermatological
Medications like Ibuprofeno may be associated, in very rare cases, with severe blistering reactions such as Stevens-Johnson Syndrome (widespread erosions affecting the skin and two or more mucous membranes and purple-colored lesions, preferably on the trunk) and toxic epidermal necrolysis (erosions on mucous membranes and painful lesions with necrosis and shedding of the epidermis). Other adverse effects are: Frequent: skin rash. Infrequent: skin redness, itching or skin swelling, purpura (purple spots on the skin). Very rare: hair loss, erythema multiforme (skin lesion), skin reactions due to light influence, inflammation of skin blood vessels. Unknown frequency: a severe skin reaction known as DRESS syndrome may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell). Exceptionally, severe skin infections and soft tissue complications may occur during chickenpox. Generalized red scaly rash, with bumps under the skin and blisters, mainly on skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis), the skin becomes sensitive to light (unknown frequency). Stop taking ibuprofeno if you experience these symptoms and seek medical attention immediately. See also section 2.
Immunological
Infrequent: transient edema in skin, mucous membranes, or sometimes in viscera (angioedema), nasal mucosa inflammation, bronchospasm (bronchial spasm that prevents air from passing to the lungs). Rare: severe allergic reactions (anaphylactic shock). In case of severe generalized hypersensitivity reaction, facial swelling, tongue and larynx swelling, bronchospasm, asthma, tachycardia, hypotension, and shock may occur. Very rare: joint pain and fever (lupus erythematosus).
Central Nervous System
Frequent: fatigue or somnolence, headache, and dizziness or feeling of instability. Rare: paresthesia (sensation of numbness, tingling, burning, etc., more frequent in hands, feet, arms, or legs). Very rare: aseptic meningitis. In most cases where aseptic meningitis has been reported with ibuprofeno, the patient suffered from some form of autoimmune disease (such as systemic lupus erythematosus or other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation.
Psychiatric
Infrequent: insomnia, anxiety, restlessness. Rare: disorientation or confusion, nervousness, irritability, depression, psychotic reaction.
Auditory
Frequent: vertigo. Infrequent: ringing or buzzing in the ears. Rare: hearing difficulty.
Ocular
Infrequent: vision changes.Rare: abnormal or blurred vision.
Hematological
Rare: decreased platelets, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and skin paleness), decreased granulocytes (a type of white blood cell that may predispose to infections), pancytopenia (deficiency of red, white blood cells, and platelets in the blood), agranulocytosis (very significant decrease in granulocytes), aplastic anemia (bone marrow failure to produce different types of cells), or hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudo-influenza symptoms, extreme fatigue, nasal and skin bleeding. Very rare: prolonged bleeding time.
Renal
Based on experience with NSAIDs in general, cases of interstitial nephritis (kidney disorder), nephrotic syndrome (disorder characterized by protein in the urine and body swelling), and renal failure (sudden loss of kidney function) cannot be excluded.
Hepatic
Medications like ibuprofeno 600 mg may be associated, in rare cases, with liver damage. Other rare adverse effects are: hepatitis (liver inflammation), liver function abnormalities, and jaundice (yellowing of the skin and eyes). Unknown frequency: liver failure (severe liver deterioration).
General
Worsening of inflammation during infectious processes.
To date, no severe allergic reactions have been reported with ibuprofeno 600 mg, although they cannot be ruled out. The manifestations of this type of reaction could be fever, skin rash, abdominal pain, severe and persistent headache, nausea, vomiting, facial swelling, tongue and throat swelling, difficulty breathing, asthma, palpitations, hypotension (lower than usual blood pressure), or shock.
If any of the following adverse effects occur, discontinue treatment and seek medical attention immediately:
Adverse Effect Reporting
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the national reporting system included in www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away in drains or trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Core
Croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, colloidal anhydrous silica, magnesium stearate, purified water.
Coating
Hypromellose, titanium dioxide (E-171), talc, purified water, and propylene glycol.
Product Appearance and Package Contents
Oval, biconvex, and white film-coated tablets. They are available in packages of 40 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Farmalider, S.A.
C/ La Granja, 1 3ª Planta
Spain
Manufacturer:
FARMALIDER, S.A,
C/Aragoneses, 15 28108
Alcobendas (Madrid)
Spain
Or
FROSST IBÉRICA, S.A.,
Vía Complutense, 140, 28805
Alcalá de Henares, Madrid
Spain
Or
PHARMALOOP, S.L.
C/ Bolivia, 15 - Polig Industrial Azque
Alcalá de Henares, 28806 Madrid
Spain
Date of the last revision of this prospectus:November2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es